Transcript: Nightly Business Report – May 8, 2017

ANNOUNCER: This is NIGHTLY BUSINESS REPORT with Tyler Mathisen and Sue
Herera.

SUE HERERA, NIGHTLY BUSINESS REPORT ANCHOR: Risk assessment. Is a rare
confluence of events potentially signaling the all clear for investors?

TYLER MATHISEN, NIGHTLY BUSINESS REPORT ANCHOR: The Oracle (NASDAQ:ORCL)
speaks. The big mistake Warren Buffett says some investors like you may be
making.

HERERA: Hot topic. An old drug gets a new price tag to treat a rare and
debilitating condition.

Those stories and more tonight on NIGHTLY BUSINESS REPORT for Monday, May
8th.

MATHISEN: Good evening, everyone, and welcome.

Well, the gains were small today, minuscule really. But they were good
enough to lift the S&P 500 and NASDAQ composite to all-time closing highs.
Investors seemingly concluded that the market had dodged yet another risk.
Namely, that France might elect a far right opponent of the European Union
and the euro currency.

Well, the French for now voted for a moderate and the status quo. And that
was enough to let investors globally focus not on European vote counts, but
on the improving health of Europe`s economies and stock markets, which has
been climbing.

We begin tonight with two reports. Bob Pisani takes a look at the risk to
the market and whether they are lessening. But first, Michelle Caruso-
Cabrera in Paris.

(BEGIN VIDEOTAPE)

MICHELLE CARUSO-CABRERA, NIGHTLY BUSINESS REPORT CORRESPONDENT: Last night
marked yet another major upset in global politics. Emmanuel Macron started
a new party only one year ago, wiped out both the socialists and the
Republicans who had dominated French politics since World War II and then
won decisively against another outsider, Marine Le Pen, to become the next
president of France.

The rest of the European Union breathed a sigh of relief. That`s because
Macron is very pro-Europe and very euro, while Marine Le Pen wanted France
to return to the franc and reestablish France`s borders. French business
owners are anxious from Macron to fulfill his campaign promise, of reducing
labor market regulation.

Boulangerie owner Sami Bouattour just won the annual best baguette in Paris
contest.

How many baguettes did you sell yesterday?

SAMI BOUATTOUR, BOULANGERIE OWNER: Two thousand.

CARUSO-CABRERA: He voted for Macron.

Can I taste it?

He tells me France`s 35-hour work week is nonsense. He works that much in
two days. Even though business is up sharply since winning the annual
contest, he`s afraid to hire more people, because if there`s another
turndown, it`s legally difficult to do layoffs. He wants Macron to change
that.

Economists say nervousness about hiring is one reason France`s unemployment
is stuck near 10 percent. On the outskirts of Paris, in Saint-Denis,
unemployment is 20 percent. And while unemployment is above average, voter
turnout here on election day, below average.

LAURENT RUSSIER, ST. DENIS MAYOR: At midday, we have 14 percent turnout.
It`s two points down between two weeks ago.

CARUSO-CABRERA: The mayor says many of its constituents didn`t like Le
Pen`s anti-immigration positions. But they also didn`t like Macron`s plan
economic reforms because they`re too free market. That viewpoint not
unique to this neighborhood. The French ministry of interior says voter
turnout across the country was the lowest in 40 years.

Leaders across Europe are cheering the outcome of the French election
because the anti-E.U. candidate was squashed. However, if you go back to
the first round of the elections two weeks ago when there were 11
candidates, nearly 50 percent of French voters chose an anti-E.U.
candidate, suggesting that the European union has a lot of work to do to
get wider acceptance here in France, despite the outcome of yesterday`s
elections.

For NIGHTLY BUSINESS REPORT, Michelle Caruso-Cabrera, Paris.

(END VIDEOTAPE)

HERERA: As we mentioned at the of our program tonight, slight gains were
all it took for the NASDAQ and S&P 500 to close at new highs. The Dow
Jones Industrial Average rose five points to 21,012, the NASDAQ tacked on
just two, and the S&P 500 was just a tick higher.

The markets were uncommonly calm today. In fact, the so-called fear gauge
known as the VIX slid to its lowest level in nearly a quarter century.

So, we asked Bob Pisani to take a look whether risks to the market have
really lessened. Here is his report.

(BEGIN VIDEOTAPE)

BOB PISANI, NIGHTLY BUSINESS REPORT CORRESPONDENT: Is the stock market
priced for perfection? Well, it sure is. But the data points are just
about as close to perfect as you could ask for.

First with the French election over, geopolitical risk is much lower.

Second, earnings are above expectation for Europe and the U.S. and full
year guidance has been strong.

Third, the U.S. economy appears to be improving. With April strong jobs
report, it`s looking likely that the first quarter`s weak numbers of just
an anomaly and the Fed is looking pretty prescient. They call that first
quarter data transitory.

Fourth, the Federal Reserve is essentially out of the picture right now.
Traders are expecting two rate hikes, and nothing`s happened recently
that`s changed that view. The economic data is good, but it`s not too
good.

And finally, tax cuts are now in play.

This is a pretty rare confluence of events. Lower risks right across the
board. It`s not surprising that world markets are at new highs, with
Germany and the U.S. at historic highs, France and Japan is better than 12-
month highs.

So, is the U.S. market expensive? Yes, it is, by historic standards, but
not dramatically so. So, why aren`t traders more excited about all the new
highs? Partly, it`s because the highs have come on low volume and low
volatility. But that`s not surprising either. Prices are too high to make
buyers enthusiastic.

But sellers are not enthusiastic either, because everyone believes that a
modest drop in the market will only be met with more buying. Why sell?

So, the bottom line, for the moment, the market is essentially saying:
don`t worry, be happy.

For NIGHTLY BUSINESS REPORT, I`m Bob Pisani at the New York Stock Exchange.

(END VIDEOTAPE)

MATHISEN: Peter Donisanu joins us now to talk more about the U.S. and
global markets. He`s an investment strategy analyst at Wells Fargo
(NYSE:WFC).

Mr. Donisanu, welcome. Good to have you with us.

You heard Bob Pisani conclude his report by saying the VIX seemed to be
saying to investors, don`t worry, be happy. Should we be worried about
that?

PETER DONISANU, WELLS FARGO INVESTMENT STRATEGY ANALYST: Well, you know,
we`ve noticed that the VIX has gone down, trended lower as markets have
moved higher. You know, we believe that the U.S. markets and global
markets generally are reflecting more positive economic environment and an
improvement in the earnings environment for not only U.S., but
international companies as well.

HERERA: So, Peter, if I`m a long-term investor, do I still put cash to
work here, given the run that this market has had, or are there other areas
around the globe that you think maybe provide more return?

DONISANU: Yes. So, you know, after the run that we`ve had in the U.S.
markets this year, we think this is a good opportunity to take some cash
off the table out of the U.S., and put some of that money to work
internationally.

MATHISEN: Where, for example? Would you be putting money into developed
Europe now that apparently some of the sort of existential risks to the
European Union have lessened or would you be looking elsewhere?

DONISANU: Yes. So, we like to invest internationally across both
developed and emerging market economies. We like to do so on a regional
basis. So, within developed markets, we like to allocate money.

We have an actual favorable view to the Pacific region, which includes
Japan, Australia, Hong Kong, Singapore. We believe that improving economic
and earnings fundamentals there have warranted higher valuations.

In terms of Europe, we`ve also seen improving economic and earnings
valuations, or fundamentals there as well. But we believe that the markets
have come too far, too fast over the past couple of weeks. And we
encourage investors to wait at least a few weeks as investors work to
consolidate. We saw some of that consolidation in markets today after a
strong run-up last week.

MATHISEN: Finish your thought. Yes?

DONISANU: Sure. And I was going to say, emerging markets favor emerging
Asia, which includes China and India. And we don`t like markets in Latin
America or emerging Europe.

MATHISEN: All right. Thanks very much, Peter. We appreciate it.

Peter Donisanu with Wells Fargo (NYSE:WFC).

DONISANU: Thank you.

HERERA: Warren Buffett says he never wants to be out of the stock market.
And one stock the chairman and CEO of Berkshire Hathaway (NYSE:BRK.A) has
faith in is Apple (NASDAQ:AAPL). Well, shares of Apple (NASDAQ:AAPL)
climbed today, reaching a market cap of $800 billion in trading, making the
world`s most valuable publicly traded company worth even more.

Becky Quick interviewed Mr. Buffett this morning following his company`s
annual meeting this weekend in Omaha.

(BEGIN VIDEOTAPE)

BECKY QUICK, NIGHTLY BUSINESS REPORT CORRESPONDENT: There`s a lot Warren
Buffett says he doesn`t know when it comes to stocks. He says he doesn`t
know where the market will close today and he doesn`t know where it close a
year from now and he doesn`t know where interest rates are headed either.

But there`s one thing that he`s certain about, and that is that stocks are
a better investment than bonds.

WARREN BUFFETT, BERKSHIRE HATHAWAY CEO: I would say anybody that prefers
bonds to stocks is making a big mistake. I`ve been saying that year after
year after year. Now, I won`t say that under all circumstances.

But it is ridiculous, in my view, for somebody to buy 30-year bond, and
some countries 50-year bonds and so on at these rates, in preference to
buying stocks. Stocks will bounce around a lot more, and they can go down
50 percent, but a 30-year bond can get down 50 percent, too, at these
rates. Bonds are a terrible choice against stocks.

QUICK: He also spent a lot of time at the shareholders meeting talking
about a subject he rarely touches on there and has touched in the past, and
that is technology. He says that Amazon (NASDAQ:AMZN) is a great company,
but he wouldn`t buy the stock right now. He said he missed that one.
However, Apple (NASDAQ:AAPL) is a different story.

BUFFETT: The shares when we bought them at least were much more reasonable
in relation to current earnings. Apple (NASDAQ:AAPL) didn`t have to do a
lot better in the future than they were doing at the current time. When
you get into a Google (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN), you`re paying
for the future more. But they may well have a better future. I mean, that
may be more than justified.

And Apple (NASDAQ:AAPL), I wouldn`t say is easy for me to understand than
Google (NASDAQ:GOOG) now perhaps, or Amazon (NASDAQ:AMZN) now. Certainly
would have been five years ago. It`s amazing where Apple`s ended up with
consumers. I mean, I can very easily determine the competitive position of
Apple (NASDAQ:AAPL) now and who`s trying to chase them and how easy it is
to chase them.

QUICK: For NIGHTLY BUSINESS REPORT, I`m Becky Quick in Omaha.

(END VIDEOTAPE)

MATHISEN: Still ahead, unusual alliance as competition in the wireless
sector heats up. Two companies are doing something completely different.

(MUSIC)

MATHISEN: It`s official. Sinclair will pay about $4 billion for Tribune
Media, and its 42 local stations, beating out 21st Century Fox. The
combined companies will create the largest single group of television
stations in the nation. The chairman of the FCC last month reinstated a
rule that helped station owners get around current audience caps, and he
has recently said he wants to loosen TV ownership rules. Shares of Tribune
rose, Sinclair`s fell.

HERERA: The bidding war for Straight Path Communications is intensifying.
The wireless spectrum holder received a buyout bid nearly double its offer
from AT&T (NYSE:T). The company behind the new bid has not been disclosed.
“The Wall Street Journal” reported last month that Verizon (NYSE:VZ) was
seeking to buy Straight Path`s high frequency airwaves licenses. AT&T
(NYSE:T) has three days to respond. Straight Path shares today soared
nearly 33 percent. Over the past month, the stock is up 480 percent.

MATHISEN: Check that out over a year, wow.

Meantime, Comcast (NASDAQ:CMCSA) (NYSE:CCS) and Charter Communications
(NASDAQ:CHTR) are joining forces to better compete in the wireless
industry.

Julia Boorstin takes a look at the unusual and complex venture.

(BEGIN VIDEOTAPE)

JULIA BOORSTIN, NIGHTLY BUSINESS REPORT CORRESPONDENT: Comcast
(NASDAQ:CMCSA) (NYSE:CCS) and Charter are partnering for one year to
improve their position in the competitive wireless market. This ahead of
Comcast (NASDAQ:CMCSA) (NYSE:CCS) launching a wireless service this year
and Charter entering the market next year, both using Verizon`s network in
their cable footprint. The two companies say they won`t buy other wireless
companies or make related deals without consulting with each other firs.

The partnership aims to help them save on costs, and better compete with
AT&T (NYSE:T), T-Mobile and Sprint. They`ll partner on back end issues
such as billing and will encourage customers to use their Wi-Fi hot spots
whenever possible.

AMY YONG, MACQUARIE RESEARCH: From a customer perspective, I think we`ve
all seen that cord-cutting is obviously happening more rapidly than we saw
it. But these companies want to have a relationship with consumers. And
this is one way to do that. So, the more service they can offer in the
bundle, the better they can make that bundle, obviously, their customers
attention is better from a consumer standpoint.

BOORSTIN: Analysts say this puts a hold on any big telco acquisitions by
either cable giant. Comcast (NASDAQ:CMCSA) (NYSE:CCS) shares were flat
today on the news, while Charter shares traded down after rising in recent
months on speculation about potential telecom deals. Analysts say this
could boost chances of a Sprint and T-Mobile merger, or even Comcast
(NASDAQ:CMCSA) (NYSE:CCS) and Charter eventually merging, though regulatory
hurdles could be impossibly high.

YONG: It`s a first step of probably a longer term partnership. Obviously,
the two don`t compete with each other, so it`s kind of spirit of
competition, if you will. But I wouldn`t rule out an acquisition of T-
Mobile or Sprint down the road. And I think, if they`re serious about
competing in the wireless market, they ultimately have to have owner
economics in wireless.

BOORSTIN: The question then is what comes when the deal expires in a year,
as mobile video and revenue from wireless subscriptions play a bigger role
in the cable giant`s balance sheets.

For NIGHTLY BUSINESS REPORT, I`m Julia Boorstin in Los Angeles.

(END VIDEOTAPE)

MATHISEN: We should point out, Comcast (NASDAQ:CMCSA) (NYSE:CCS) is the
parent company of CNBC, which produces this program.

HERERA: Coach (NYSE:COH) is buying Kate Spade, and that`s where we begin
tonight`s “Market Focus”.

The handbag and accessories maker said it was acquiring its smaller rival
for nearly $2.5 billion. The new deal highlights coach`s ongoing efforts
to attract a younger demographic with the company saying that Kate Spade
has a strong awareness among millennials. Coach (NYSE:COH) shares rose 4
percent to $44.71, while shares of Kate Spade popped 8 percent to $18.38.

Newell Brand raised its guidance for the year following better than
expected earnings. The maker of household products like Sharpie markers
and Elmer`s Glue said results were hurt by a gain related to the sale of
the company`s tool business. Newell also lifted its quarterly dividend 21
percent to 23 cents a share. And the shares jumped almost 12 percent,
$51.93.

Tyson Foods (NYSE:TSN) said fires at two facilities hurt its production
that`s causing the meat producer to report earnings that missed
expectations. Revenue inched lower, but was still stronger than expected.
Tyson also said Florida`s attorney general requested information from the
company regarding possible anti-competitive behavior. As a result of all
of that, the shares fell 6 percent to $59.48.

MATHISEN: The activist investor Elliott Management disclosed more than 15
percent stake in the software maker Gigamon. In a regulatory filing,
Elliott Management called Gigamon shares undervalued and said it wants to
speak with the company`s board about maximizing shareholder value. Shares
of Gigamon took off on the news, rising 17 percent to $41.20.

Profit rose more than expected at Marriott as the world`s largest hotel
chain benefited from more people booking more rooms at higher rates. The
company also posted revenue that topped street estimates. Shares initially
rose in after-hours trading but they ended the session down a fraction at
$96.37.

Meantime, Hertz saw its loss widen in the latest quarter, sharply missing
analyst expectations, revenue also lower than expected. Despite the
disappointing results, the car rental company said it is seeing progress in
its turn-around efforts. Shares initially fell after hours. They also
ended the regular day down, but only marginally, at $14.91.

HERERA: A drug to treat muscular dystrophy faced backlash when the price
tag was set at nearly $90,000. Today, the medicine has a new owner, and a
new list price.

Meg Tirrell has the details.

(BEGIN VIDEOTAPE)

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Christine McSherry is
used to a fight. Her son Jett was diagnosed at age 5 with Duchenne
muscular dystrophy, a rare debilitating condition that put him in a wheel
chair just before he turned 14. One thing she didn`t have to plan on
having to fight for was an access to an older drug her son was already
using.

Jet has been taking a steroid called deflazacort since he was 8 years old.
It wasn`t approved in the U.S. So, McSherry, along with a number of other
families of kids with Duchenne, imported the drug from overseas. It costs
about $1,200 a year out of pocket.

It got a new price tag, $35,000 a year for a patient in the U.S., weighing
25 kilograms or about 55 pounds.

CHRISTINE MCSHERRY, JEFF FOUNDATION EXEC. DIR.: Thirty-five thousand
dollars per 25 kilograms, it`s pretty aggressive I would think.

TIRRELL: PTC Therapeutics which set the price says it, quote, represents
sustainable pricing which balances providing access to eligible patients in
the United States while maintaining sufficient infrastructure, including
continued investment in Duchenne.

But McSherry says the drug`s cost may be more than $35,000, if patients
like her son weigh more than 25 kilograms.

MCSHERRY: My son is probably on the highest — one of the highest doses,
almost 50 milligrams a day.

TIRRELL: She estimates the cost of more than $100,000 a year. And she`s
concerned her old system of importing the drug is going away now it`s
improved in the U.S.

The drug`s route to these prices a complicated one. Earlier this year, a
private drug company called Marathon Pharmaceuticals acquired rights to
deflazacort and took it through the FDA approval process. Then, it set an
annual price in the U.S. of $89,000, generating an immediate outcry from
the patient community. That`s when PTC Therapeutics stepped in, paying
$140 million to Marathon to acquire deflazacort.

RITU BARAL, COWEN AND COMPANY: PTC at that point came in, acquired the
asset, and had sort of, for lack of a better word, resunk the commercial
approach to the drug.

TIRRELL: But it`s new price tag is still drawing criticism.

ERIK GORDON, UNIVERSITY OF MICHIGAN ROSS SCHOOL OF BUSINESS: It`s the drug
business back in trouble again over pricing. They just don`t seem to learn
their lesson.

TIRRELL: Insurers and pharmacy benefits managers may pose barriers.
Already, a number have said they will require patients to try a cheaper
steroid first before they`ll pay for deflazacort. Both PTC and many
patients argue deflazacort has a better safety profile. So, this is a
headache Christine McSherry says the community doesn`t need.

MCSHERRY: The burden really is with the patients and the families. We are
the ones who are going to have to write all these appeals and appeal to our
payers to try to get this drug covered.

TIRRELL: And in a changing environment for health care in the U.S., they
worry about paying for something else.

For NIGHTLY BUSINESS REPORT, I`m Meg Tirrell.

(END VIDEOTAPE)

HERERA: Shares of PTC Therapeutics had a rough day. They fell nearly 12
percent.

MATHISEN: While the price of prescription drugs is one hot topic in
Washington, and another in the U.S.`s relationship with China. And despite
tough talk over trade, some U.S. officials are also actively seeking
investment from the world`s second largest economy.

Kayla Tausche has our story.

(BEGIN VIDEOTAPE)

KAYLA TAUSCHE, NIGHTLY BUSINESS REPORT CORRESPONDENT: A month after a
meeting between the U.S. and Chinese presidents, a select group of Chinese
investors crisscrossed the United States, looking for investing
opportunities in the Trump administration. In Washington, the group
discussed changing U.S. policy toward China.

Helen Ye helps coordinate the trip with the American Chamber of Commerce.

HELEN YE, OLGILVY CHINA OUTBOUND PRACTICE: This administration is very
different from previous. You won`t understand (ph). And then they won`t
say how, where is best a place for them for investment, how they should
work with U.S. local regulators.

TAUSCHE: In Omaha, Nebraska, the delegation visited Warren Buffett`s
annual gathering, met with executives in the railroad and agricultural
industries and praised by the state`s governor, Pete Ricketts.

GOV. PETER RICKETTS (R), NEBRASKA: We actually received our first
investment from a Chinese company back in 2008. And part of the reason you
do trade missions is not only to open up markets in China, but to look for
those investors that want to invest in Nebraska to be able to help create
job opportunities here.

TAUSCHE: Since the financial crisis, China has invested $140 billion into
the U.S., increasing more than five-fold to $50 billion last year, much of
it in real estate. Investors worry the president`s tough talk on China —

DONALD TRUMP, PRESIDENT OF THE UNITED STATES: No friendship is
strengthened through economic abuse.

TAUSCHE: — could change that, with trade a point of contention. China
reported a trade surplus with the U.S. that widened in April.

Kevin Guan said his family business which makes compressor parts and has an
office in Kentucky is looking for clarity on the administration`s trade
policy which affects whether it will expand.

KEVIN GUAN, SEDNAIR PRESIDENT: We will wait for a while. If there`s
really a trade war, so we`re prepared for the materials price, if there`s
any changes dramatically in the future.

TAUSCHE: Jeremy Shia runs a yoga sportswear and equipment company. His
goal in joining the trip is finding partners to build his brand. The first
step? A dialogue.

JEREMY XIA, YOKALAND PRESIDENT: Political leaders, they know that — take
a picture, then all — have visions. But actually, day-to-day operations,
we need, you know, foundations. We need a base labor, you know,
communications to work together to figure out the — facing (ph) these
challenges together.

TAUSCHE: Attendees say these conversations will be years in the making.
But the White House hopes to repair its relationship with China in the
shorter term, setting a late July deadline to resolve long-standing trade
issues.

For NIGHTLY BUSINESS REPORT, I`m Kayla Tausche, Washington.

(END VIDEOTAPE)

HERERA: Coming up, a look at where the jobs are.

(BEGIN VIDEOTAPE)

KATE ROGERS, NIGHTLY BUSINESS REPORT CORRESPONDENT: I`m Kate Rogers
(NYSE:ROG) in Baltimore. And tonight on NIGHTLY BUSINESS REPORT, we`re
going to tell you why nurses are said to have very solid job prospects in
the years to come.

(END VIDEO CLIP)

(MUSIC)

MATHISEN: As we reported last week, the health care sector created more
than 35,000 jobs last month. If you look back over the past few years,
that number balloons to more than a million jobs.

And as Kate Rogers (NYSE:ROG) reports from Baltimore, demand is especially
strong for nurses.

(BEGIN VIDEOTAPE)

ROGERS: As a child, Jasmine Noronha wanted to become an accountant. But a
love of science took her down a different path — nursing.

JASMINE NORONHA, UNIVERSITY OF MARYLAND NURSING STUDIES: I found nursing
as a great way of doing science, while also talking to people.

ROGERS: Today, she`s advancing her degrees in nurse practitioner at the
University of Maryland, hoping to be placed in a rural hospital like the
one where she`s currently training on the eastern shore of the state.

NORONHA: I really enjoy the patients there. A lot of patients haven`t
sought care in a couple years because they don`t know how important it is
for their diet and nutrition to go see a doctor.

ROGERS: Nursing students are said to have very solid job prospects in the
years to come. The Bureau of Labor Statistics says demand for registered
nursing will grow by some 16 percent through 2024 adding half a million new
jobs. Salaries within the industry can range widely depending on degree
and location from $45,000 a year up to $150,000 annually.

The University of Maryland has nearly 1,900 students enrolled in nursing
programs this year, up from 1,700 in 2010. The school is doing its best to
get ahead of a projected nursing shortage in the state in the years to
come.

JANE KIRSCHLING, UNIVERSITY OF MARYLAND SCHOOL OF NURSING: We feel a
personal responsibility for making sure that Maryland has enough registered
nurses, and professional nurses in order to meet the care needs of the
residents of Maryland.

ROGERS: But the shortage is an issue beyond Maryland.

PAMELA CIPRIANO, AMERICAN NURSES ASSOCIATION PRESIDENT: We`re beginning to
see growing shortages in different states, and different geographic
regions.

ROGERS: Medical facilities in inner cities and rural areas are
particularly struggling to attract and retain talent.

CIPRIANO: Rural areas often have lower salaries. That`s also true with
smaller facilities. We see a real distribution issue that is only getting
worse.

ROGERS: Madison Health in Macon, Georgia, is the second largest hospital
in the state and is competing with nearby Atlanta for hires, which offers
better salaries and a vibrant social life.

TRACEY BLALOCK, NAVICENT HEALTH CHIEF NURSING OFFICER: We`re after a
deficit of 150 nurses at this time.

ROGERS: The aging population is also a major contributing factor.

BLALOCK: Individuals in our community are living longer and longer. With
chronic diseases which requires us to need more nurses than we have had to
historically. Many of our nurses are in the category of being baby
boomers, and they`re seeking retirement.

ROGERS: The new generation of nurses like Noronha are eager to step in,
fully recognizing the job`s challenges and rewards.

NORONHA: At the end of the day when I go home, I might not have a hard day
and not sat down or not eaten lunch, but I can look back on my day and say
I`ve made a difference in someone`s life.

ROGERS: For NIGHTLY BUSINESS REPORT, I`m Kate Rogers (NYSE:ROG),
Baltimore.

(END VIDEOTAPE)

HERERA: And that`s why you do it, right?

MATHISEN: That`s right.

HERERA: All right.

MATHISEN: Their calling.

HERERA: On that note, that`s NIGHTLY BUSINESS REPORT for tonight. I`m Sue
Herera. Thanks for joining us.

MATHISEN: And I`m Tyler Mathisen. Thanks from me as well. Have a great
evening. We`ll see you back here tomorrow.

END

Nightly Business Report transcripts and video are available on-line post
broadcast at http://nbr.com. The program is transcribed by ASC Services II
Media, LLC. Updates may be posted at a later date. The views of our guests
and commentators are their own and do not necessarily represent the views
of Nightly Business Report, or CNBC, Inc. Information presented on Nightly
Business Report is not and should not be considered as investment advice.
(c) 2017 CNBC, Inc.

 

This entry was posted in Transcripts. Bookmark the permalink.

Leave a Reply